[Prognostic Value of CD56 Expression in Newly Diagnosed Multiple Myeloma Patients and Its Related Factors] [0.03%]
CD56在新诊断多发性骨髓瘤患者中的预后价值及其影响因素分析
Xiao-Xue Wang,Lu-Lu Zhang,Tong Wang et al.
Xiao-Xue Wang et al.
Objective: To analyze the effect of CD56 expression on the prognosis of newly diagnosed multiple myeloma (MM) patients and explore the relationship between CD56 with clinical characteristics. ...
[Expression of NAMPT in Patients with Multiple Myeloma and Its Correlation with Clinical Manifestation] [0.03%]
多发性骨髓瘤患者NAMPT的表达及临床意义分析
Ya-Ru Wang,Yan-Ping Ma
Ya-Ru Wang
Objective: To analyze the expression level of nicotinamide phosphoribosyltransferase (NAMPT ) in bone marrow of multiple myeloma (MM) patients and its correlation with clinicopathological features, clinical efficacy and p...
[Prognostic Value of Pre-treatment Albumin/Fibrinogen Ratio in Patients with Diffuse Large B-cell Lymphoma] [0.03%]
治疗前血清白蛋白/纤维蛋白原比例对弥漫大B细胞淋巴瘤患者预后的价值
Hong Deng,Liang Zhang,Hong-Yan Wang et al.
Hong Deng et al.
Objective: To investigate the value of pre-treatment albumin/fibrinogen ratio (AFR) on the prognosis of patients with diffuse large B-cell lymphoma (DLBCL). ...
[Establishment and Clinical Significance of Prognostic Nomogram Model for Diffuse Large B-Cell Lymphoma Based on Immunohistochemistry Markers and International Prognostic Index Scores] [0.03%]
基于免疫组织化学标记物和国际预后指数评分的弥漫大B细胞淋巴瘤预后 nomogram模型的建立及临床意义
Ya-Wen Xu,Yu-Lan Zhou,Fan-Cong Kong et al.
Ya-Wen Xu et al.
Objective: To retrospectively analyze clinical characteristics and survival time of patients with diffuse large B-cell lymphoma (DLBCL), detect prognosis-related markers, and establish a nomogram prognostic model of clini...
[Multiomics and Multidimensional Testing for Efficacy Monitoring of Patients with Lymphoma] [0.03%]
[淋巴瘤患者的疗效监测的多组学和多维度检验]
Xin-Hua Wang,Yan-Xin Yang,Ying-Jun Wang et al.
Xin-Hua Wang et al.
Objective: To explore the role of a new blood-based, multiomics and multidimensional method for evaluating the efficacy of patients with lymphoma. Methods...
[Effect of MELK Inhibitor OTSSP167 on Diffuse Large B-Cell Lymphoma] [0.03%]
MELK抑制剂OTSSP167对弥漫大B细胞淋巴瘤的作用机制研究
Jun-Yi Zhou,Hao Huang,Yan Zhuang et al.
Jun-Yi Zhou et al.
Objective: To investigate the effect of MELK inhibitor OTSSP167 against diffuse large B-cell lymphoma (DLBCL). Methods: The effect of O...
[Regulation of Baicalin on Growth of Extranodal NK/T Cell Lymphoma Cells through FOXO3/ CCL22 Signaling Pathway] [0.03%]
黄芩素通过FOXO3/CCL22信号通路调节NK/T细胞淋巴瘤细胞的生长
Xiao-Hui Duan,Hong Li,Yao Lyu et al.
Xiao-Hui Duan et al.
Objective: To investigate the effect of baicalin on the growth of extranodal NK/T cell lymphoma (ENKTCL) cells and its related mechanism. Methods: ...
[Clinical Features and Outcomes of the Patients with B-Cell Chronic Lymphoproliferative Disease in the New Drug Era] [0.03%]
新药时代B细胞慢性淋巴增生性疾病患者的临床特征及预后分析
Cheng-Bo Xu,Min Hu,Jian-Zhen Shen et al.
Cheng-Bo Xu et al.
Objective: To analyze the clinical characteristics of the patients with B-cell chronic lymphoproliferative disease（B-CLPD） in the new drug era and the effect of new drug treatment on efficacy and survival. ...
[Expressions and Clinical Significance of Notch1 and Hes1 in Diffuse Large B-Cell Lymphoma] [0.03%]
诺特赫1和hes1在弥漫性大B细胞淋巴瘤中的表达及其临床意义
Yan Liu,Sha-Sha Xu,Xiao-Ning Wang et al.
Yan Liu et al.
Objective: To investigate the expressions of Notch1 and Hes1 in diffuse large B-cell lymphoma (DLBCL), and their correlations with clinical features. Meth...
[Influence of Pre-treatment Lymphocyte/Monocyte Ratio and Neutrophil/Lymphocyte Ratio on the Prognosis of Patients with Extranodal NK/T-Cell Lymphoma] [0.03%]
预处理淋巴细胞/单核细胞比值和中性粒细胞/淋巴细胞比值对结外NK/T细胞淋巴瘤患者预后的影响分析
Xiao-Yu Deng,Ying-Yi Wang,Qian-Qian Dang et al.
Xiao-Yu Deng et al.
Objective: To explore the influence of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) on the prognosis of patients with extranodal NK/T cell lymphoma (ENKTL). ...